Researchers at the University of Virginia Health System have identified a molecular target, or receptor, for potential drugs to treat acute respiratory distress syndrome (ARDS), a sudden and life-threatening failure of the lung. Interestingly, the receptor is in the same class that gives people their sense of sight, smell and taste (G-protein coupled receptors.)

In ARDS, patients cannot breathe on their own because fluid gets into the lungs. Essentially, the body's immune system causes lung inflammation and accumulation of fluid in the air sacs, or alveoli, leading to low blood-oxygen levels. Up to 30 percent of patients in intensive care units can die from ARDS. There is no current therapy other than general life support and putting patients on a breathing machine. If they survive, many people face long-term lung problems. Common causes of ARDS are pneumonia, septic shock, trauma, or inhaling chemicals.

The receptor identified by UVa doctors is called CXCR2. It's expressed on the endothelial cells that line the blood vessels of the lung and on inflammatory leukocytes. Using animal models, UVa doctors have found that CXCR2 attracts white blood cells called neutrophils into the lung, a key event in the early development of ARDS. CXCR2 has been characterized in the past, but the endothelial cell effects define a new role for this receptor in the body's physiology.

"We can't say yet that if you target this receptor you will stop ARDS," said Klaus Ley, M.D., Ph.D., director of the cardiovascular research center at UVa. "But it is reasonable to be hopeful and to pursue this type of research that might one day translate into clinical application." Ley is senior author on a paper describing the receptor CXCR2 in the Feb. 16, 2006 "Online First Articles" of The Journal of Clinical Investigation found on the web at www.jci.org.

Dr. Jrg Reutershan, M.D., an anesthesiologist from Germany doing research in Ley's lab, discovered that CXCR2 expres
'"/>

Contact: Bob Beard
bobbeard@virginia.edu
434-982-4490
University of Virginia Health System
21-Feb-2006

Page: 1 2
Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. Barrow scientists make headlines for their research on fixational eye movements
3. UD scientists invent novel hydrogels for repairing, regenerating human tissue
4. UK scientists set their sights on cure for AMD
5. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
6. Smart mice teach scientists about learning process, brain disorders
7. Why predicting the next influenza pandemic is difficult and how scientists can best prepare
8. Sex and prenatal hormone exposure affect cognitive performance, Yerkes scientists find
9. AACR awards minority and other underrepresented scientists
10. Jefferson scientists find that plavix appears to be safe during and after heart bypass
11. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes